Literature DB >> 26188138

Acute-on-Chronic Liver Failure.

Sumeet K Asrani1, Douglas A Simonetto2, Patrick S Kamath3.   

Abstract

Over the past 2 decades, the concept of acute-on-chronic liver failure (ACLF) has been proposed as an alternate path in the natural history of decompensated cirrhosis. ACLF thus is characterized by the presence of a precipitating event (identified or unidentified) in subjects with underlying chronic liver disease leading to rapid progression of liver injury and ending in multi-organ dysfunction characterized by high short-term mortality. Multiple organ failure and an increased risk for mortality are key to the diagnosis of ACLF. The prevalence of ACLF ranges from 24% to 40% in hospitalized patients. The pathophysiological basis of ACLF can be explained using the following 4-part model: predisposing event, injury caused by a precipitating event, response to injury, and organ failure. Although several mathematic scores have been proposed for identifying outcomes with ACLF, it is as yet unclear whether these organ failure scores are truly prognostic or only reflective of the dying process. Treatment paradigms continue to evolve but consist of early recognition, supportive intensive care, and consideration of liver transplantation before onset of irreversible multiple organ failure.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cirrhosis; MELD; Portal Hypertension; Sepsis; Survival Scores

Mesh:

Year:  2015        PMID: 26188138      PMCID: PMC4625547          DOI: 10.1016/j.cgh.2015.07.008

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  99 in total

1.  Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.

Authors:  Thierry Gustot; Javier Fernandez; Elisabet Garcia; Filippo Morando; Paolo Caraceni; Carlo Alessandria; Wim Laleman; Jonel Trebicka; Laure Elkrief; Corinna Hopf; Pablo Solís-Munoz; Faouzi Saliba; Stefan Zeuzem; Augustin Albillos; Daniel Benten; José Luis Montero-Alvarez; Maria Teresa Chivas; Mar Concepción; Juan Córdoba; Aiden McCormick; Rudolf Stauber; Wolfgang Vogel; Andrea de Gottardi; Tania M Welzel; Marco Domenicali; Alessandro Risso; Julia Wendon; Carme Deulofeu; Paolo Angeli; François Durand; Marco Pavesi; Alexander Gerbes; Rajiv Jalan; Richard Moreau; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  Hepatology       Date:  2015-05-29       Impact factor: 17.425

2.  Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).

Authors:  Juan Cordoba; Meritxell Ventura-Cots; Macarena Simón-Talero; Àlex Amorós; Marco Pavesi; Hendrik Vilstrup; Paolo Angeli; Marco Domenicali; Pere Ginés; Mauro Bernardi; Vicente Arroyo
Journal:  J Hepatol       Date:  2013-10-12       Impact factor: 25.083

3.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

4.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

Review 5.  Role of Kupffer cells in host defense and liver disease.

Authors:  Manfred Bilzer; Frigga Roggel; Alexander L Gerbes
Journal:  Liver Int       Date:  2006-12       Impact factor: 5.828

6.  Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults.

Authors:  Yu Shi; Ying Yang; Yaoren Hu; Wei Wu; Qiao Yang; Min Zheng; Shun Zhang; Zhaojun Xu; Yihua Wu; Huadong Yan; Zhi Chen
Journal:  Hepatology       Date:  2015-04-25       Impact factor: 17.425

7.  Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis.

Authors:  J Córdoba; J Gottstein; A T Blei
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

8.  Hepatic and systemic hemodynamic derangements predict early mortality and recovery in patients with acute-on-chronic liver failure.

Authors:  Hitendra Garg; Ashish Kumar; Vishal Garg; Manoj Kumar; Ramesh Kumar; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

9.  Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

Authors:  Christine Bernsmeier; Oltin T Pop; Arjuna Singanayagam; Evangelos Triantafyllou; Vishal C Patel; Christopher J Weston; Stuart Curbishley; Fouzia Sadiq; Nikhil Vergis; Wafa Khamri; William Bernal; Georg Auzinger; Michael Heneghan; Yun Ma; Wayel Jassem; Nigel D Heaton; David H Adams; Alberto Quaglia; Mark R Thursz; Julia Wendon; Charalambos G Antoniades
Journal:  Gastroenterology       Date:  2014-12-03       Impact factor: 22.682

10.  Liver transplantation for acute-on-chronic liver failure.

Authors:  Albert C Chan; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; See Ching Chan; Kelvin K Ng; Boon Hun Yong; Alexander Chiu; Banny K Lam
Journal:  Hepatol Int       Date:  2009-08-13       Impact factor: 6.047

View more
  14 in total

Review 1.  Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  Transl Gastroenterol Hepatol       Date:  2019-10-11

2.  Integrated Analysis of Long Noncoding RNA Expression Profiles in Acute-on-Chronic Liver Failure.

Authors:  Xiaoyu Fu; Da Cheng; Yi Ouyang; Ying Li; Ronghua Li; Shifang Peng; Lei Fu
Journal:  Biomed Res Int       Date:  2021-05-18       Impact factor: 3.411

3.  A novel dynamic model for predicting outcome in patients with hepatitis B virus related acute-on-chronic liver failure.

Authors:  Ran Xue; Zhonghui Duan; Haixia Liu; Li Chen; Hongwei Yu; Meixin Ren; Yueke Zhu; Chenggang Jin; Tao Han; Zhiliang Gao; Qinghua Meng
Journal:  Oncotarget       Date:  2017-11-14

4.  Validation of prognostic scores to predict short-term mortality in patients with HBV-related acute-on-chronic liver failure: The CLIF-C OF is superior to MELD, CLIF SOFA, and CLIF-C ACLF.

Authors:  Ning Li; Chong Huang; Kang-Kang Yu; Qing Lu; Guang-Feng Shi; Jian-Ming Zheng
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

5.  Acute Liver Failure and Dengue: Alcohol Matters.

Authors:  Jose D Debes; Ashraf Ashhab
Journal:  Am J Trop Med Hyg       Date:  2017-03       Impact factor: 2.345

6.  Plasma Apolipoprotein A-V Predicts Long-term Survival in Chronic Hepatitis B Patients with Acute-on-Chronic Liver Failure.

Authors:  En-Qiang Chen; Meng-Lan Wang; Dong-Mei Zhang; Ying Shi; Do-Bo Wu; Li-Bo Yan; Ling-Yao Du; Ling-Yun Zhou; Hong Tang
Journal:  Sci Rep       Date:  2017-03-30       Impact factor: 4.379

7.  Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway.

Authors:  Tianhui Zhou; Ye Sun; Ming Li; Yongsen Ding; Rongkun Yin; Ziqiang Li; Qing Xie; Shisan Bao; Wei Cai
Journal:  Cell Death Dis       Date:  2018-05-22       Impact factor: 8.469

Review 8.  The Management of Glucocorticoid Therapy in Liver Failure.

Authors:  Ran Xue; Qinghua Meng
Journal:  Front Immunol       Date:  2019-10-23       Impact factor: 7.561

9.  Clinical performance of stem cell therapy in patients with acute-on-chronic liver failure: a systematic review and meta-analysis.

Authors:  Ran Xue; Qinghua Meng; Jinling Dong; Juan Li; Qinwei Yao; Yueke Zhu; Hongwei Yu
Journal:  J Transl Med       Date:  2018-05-10       Impact factor: 5.531

10.  Protective Effects of Taraxacum officinale L. (Dandelion) Root Extract in Experimental Acute on Chronic Liver Failure.

Authors:  Iulia Olimpia Pfingstgraf; Marian Taulescu; Raluca Maria Pop; Remus Orăsan; Laurian Vlase; Ana Uifalean; Doina Todea; Teodora Alexescu; Corina Toma; Alina Elena Pârvu
Journal:  Antioxidants (Basel)       Date:  2021-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.